Explore UAB

Subscribe to Department of Surgery News



Subscribe to Department of Surgery News



Dr. Rachael Guenter & Dr. Melanie RoseThe UAB Department of Surgery is honored to welcome two new faculty members – Dr. Melanie Rose and Dr. Rachael Guenter.

Dr. Melanie Rose

Melanie Rose, M.D., FACS, joined the Department of Surgery in May 2023 as a Clinical Assistant Professor in the Division of Vascular Surgery & Endovascular Therapy. Dr. Rose graduated from the University of South Alabama College of Medicine and continued her surgical training with a residency at the University of South Alabama Health Systems, followed by a two-year Vascular Surgery and Endovascular Therapy Fellowship at UAB.

Dr. Rose is board certified in general and vascular surgery and has a special interest in the endovascular and open treatment of peripheral vascular disease, treatment of superficial and deep venous disease, thoracic outlet syndrome, open and endovascular treatment of aortic aneurysms, and cerebrovascular disease.

She is a member of the Alpha Omega Alpha Honor Medical Society, Alabama Vascular Society, Society for Vascular Surgery, Vascular and Endovascular Surgical Society, and Southeastern Surgical Society, and a fellow of the American College of Surgeons and Society of Vascular Surgery.

Dr. Rachael Guenter

Rachael Guenter, Ph.D., joined the Department of Surgery in May 2023 as an Instructor in the Division of Surgical Oncology. She received her Ph.D. in Cancer Biology at UAB under the mentorship of Dr. Herbert Chen and her B.S. in Chemical and Biomolecular Engineering from North Carolina State University.

Dr. Guenter investigates the molecular mechanisms of neuroendocrine cancer and pancreatic ductal adenocarcinoma to develop novel therapeutic strategies.

Currently, her areas of focus include the development of novel theranostic agents for pancreatic cancers and understanding the role of Notch signaling in gastroenteropancreatic neuroendocrine tumors. She is particularly interested in developing new treatments for patients with unresectable, advanced disease. She also advocates to bring awareness to neuroendocrine cancer and aims to provide accurate information for patients and the general public.